Spot on Bob, it IS a viscous cycle, particularly "viscous" in RE where there is no established metals exchange to underpin a project, even Baotou Exchange is a bit of a Chinese construct with relatively low volumes and problematic access for ex China producers. Only ROW producer of any scale just confirmed they are not selling anything into Chinese spot mkt, 100% of sales are direct downstream.
Exactly why virtually every RE hopeful is still chasing finance to build out projects of any meaningful scale and many are taking the route of concentrates or carbonates to establish CF over a much lower capital base.
ARU's 2700ppm Th makes the export of concentrate highly unlikely, and the cost of dealing with it, along with the expense of reagents to Nolans, makes carbonates difficult, and even then they are dependent solid offtakes.
Apart from the massive CapEx required the very long lead times & lack of expertise add significantly to risk here.
- Forums
- ASX - By Stock
- ARU
- Consolidation over, Time to shine
Consolidation over, Time to shine, page-234
-
- There are more pages in this discussion • 173 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ARU (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.0¢ |
Change
-0.005(2.56%) |
Mkt cap ! $438.9M |
Open | High | Low | Value | Volume |
19.5¢ | 20.0¢ | 19.0¢ | $315.6K | 1.626M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
30 | 795813 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 472055 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 695813 | 0.190 |
37 | 1738542 | 0.185 |
50 | 2032948 | 0.180 |
33 | 2073847 | 0.175 |
43 | 4378432 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 472055 | 8 |
0.200 | 2001007 | 23 |
0.205 | 1311539 | 23 |
0.210 | 1696841 | 28 |
0.215 | 516917 | 12 |
Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
Featured News
ARU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online